R. Moore

R. Moore, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial.

Riddhi A Modi, A. Westfall, J. Willig, 2018, Contemporary clinical trials.

Lack of evidence for interaction between tobramycin and shock in their effect on renal function

E. Mellits, R. Moore, R. Ambinder, 1985, Antimicrobial Agents and Chemotherapy.

The preoperative consultation. Response to internists' recommendations.

D. Levine, R. Moore, S. Kirby, 1983, Archives of internal medicine.

Hantavirus serologies in patients hospitalized with community-acquired pneumonia.

R. Moore, P. Auwaerter, L. Mundy, 1996, The Journal of infectious diseases.

Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B.

T. Pearson, R. Moore, P. Kwiterovich, 1988, The American journal of medicine.

Neutropenia and bacterial infection in acquired immunodeficiency syndrome.

R. Chaisson, J. Keruly, R. Moore, 1995, Archives of internal medicine.

The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.

R. Chaisson, J. Bartlett, J. Gallant, 1995, Chest.

Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.

R. Chaisson, R. Moore, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Alcohol consumption and blood pressure: a comparison of native Japanese to American men.

P. Whelton, M. Klag, M. Klag, 1990, Journal of clinical epidemiology.

Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism.

G. Geller, L. Bone, R. Moore, 1989, JAMA.

Increasing incidence of avascular necrosis of the hip in HIV-infected patients.

R. Chaisson, J. Keruly, R. Moore, 2001, Journal of acquired immune deficiency syndromes.

Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.

R. Chaisson, J. Gallant, E. Erbelding, 1997, Antiviral therapy.

Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

E. Bass, W. Ravich, T. Hendrix, 1999, Health services research.

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team.

J. Bartlett, T. Quinn, C. Gaydos, 1998, Chest.

Hospitalization Rates in an Urban Cohort After the Introduction of Highly Active Antiretroviral Therapy

K. Gebo, M. Diener-West, R. Moore, 2001, Journal of acquired immune deficiency syndromes.

Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro

D. Clark, C. Sears, R. Moore, 1997, Infection and immunity.

Cryptosporidiosis in patients with AIDS: correlates of disease and survival.

R. Chaisson, D. Clark, H. Dahlman, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients.

R. Moore, P. Santora, A. Umbricht-Schneiter, 1991, The American journal of medicine.

Frequency and determinants of adverse reactions induced by high-osmolality contrast media.

N. Powe, E. Fishman, S. Zinreich, 1989, Radiology.

Long-term effects of cigarette smoking and moderate alcohol consumption on coronary artery diameter. Mechanisms of coronary artery disease independent of atherosclerosis or thrombosis?

Richard D Moore, L. Fried, T. Pearson, 1986, The American journal of medicine.

Adverse events from drug therapy for human immunodeficiency virus disease.

R. Chaisson, J. Keruly, R. Moore, 1996, The American journal of medicine.

Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.

R. Chaisson, J. Gallant, J. Keruly, 1999, AIDS (London).

Predictors of outpatient treatment retention: patient versus substance use characteristics.

D. Svikis, M. McCaul, R. Moore, 2001, Drug and alcohol dependence.

Prevalence, detection, and treatment of alcoholism in hospitalized patients.

G. Geller, L. Bone, R. Moore, 1989, JAMA.

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.

J. Gallant, J. Keruly, R. Moore, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adverse reactions to contrast media: factors that determine the cost of treatment.

N. Powe, E. Steinberg, R. Moore, 1993, AJR. American journal of roentgenology.

Prevention of opportunistic infections in the era of improved antiretroviral therapy.

R. Chaisson, R. Moore, R. D. Moore, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.

R. Chaisson, D. Richman, J. Keruly, 1992, Archives of internal medicine.

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.

R. Moore, P. Lietman, C. R. Smith, 1984, The Journal of infectious diseases.

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids.

J. Eustace, P. Scheel, R. Moore, 2000, Kidney international.

Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

M L Terrin, F. Barton, O. Castro, 1996, Medicine.

Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting

Richard D Moore, R. Chaisson, J. Bartlett, 1993, AIDS.

Risk factors for cryptococcal meningitis in HIV-infected patients.

R. Chaisson, R. Moore, K. A. Oursler, 1999, AIDS research and human retroviruses.

Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea.

F. Barton, S. Eckert, G. Dover, 1995, Controlled clinical trials.

Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.

R. Chaisson, M. Glesby, R. Moore, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis.

N. Powe, R. Moore, J. Sanders, 1991, The Journal of infectious diseases.

Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.

R. Chaisson, J. Keruly, R. Moore, 2000, American journal of respiratory and critical care medicine.

The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications.

R. Chaisson, J. Gallant, R. Moore, 1998, Chest.

Anemia and survival in HIV infection.

R. Chaisson, J. Keruly, R. Moore, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Disulfiram treatment of alcoholism.

R. Moore, C. Wright, Richard D. Moore, 1990, The American journal of medicine.

Impact of opportunistic disease on survival in patients with HIV infection

R. Chaisson, J. Gallant, J. Keruly, 1998, AIDS.

A clinicopathologic analysis of AIDS‐related cryptosporidiosis

D. Clark, J. Lumadue, C. Sears, 1998, AIDS.

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

R. Chaisson, D. Thomas, M. Sulkowski, 2000, JAMA.

Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.

R. Chaisson, R. Moore, R D Moore, 1995, The American journal of gastroenterology.

An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age.

G. Dover, R. Moore, G. Serjeant, 1995, Blood.

Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.

Richard D Moore, O. Platt, E. Orringer, 1992, Blood.

Race, sex, drug use, and progression of human immunodeficiency virus disease.

R. Chaisson, J. Keruly, R. Moore, 1995, The New England journal of medicine.

Uptake and virological outcomes of single‐ versus multi‐tablet antiretroviral regimens among treatment‐naïve youth in the HIV Research Network

P. Korthuis, J. Aberg, K. Gebo, 2019, HIV medicine.

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens.

J. Gallant, R. Moore, S. Barnett, 1999, AIDS.

Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent.

R. Moore, S. R. Goodwin, K. Sullivan, 1999, Critical care medicine.

Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy.

R. Chaisson, J. Keruly, R. Moore, 2000, JAMA.

Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort

J. McArthur, K. Carter, P. Hauer, 2006, Neurology.

Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.

R. Moore, 2000, Seminars in hematology.

Natural history of HIV infection in the era of combination antiretroviral therapy.

R. Chaisson, R. Moore, R D Moore, 1999, AIDS.

Studies of risk factors for aminoglycoside nephrotoxicity.

R. Moore, P. Lietman, C. R. Smith, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.

R. Chaisson, T. Sterling, R. Moore, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use a high resolution melting assay to compare and env diversity in adults with different stages of HIV infection.

R. Brookmeyer, O. Laeyendecker, S. Buchbinder, 2011 .

Improving HIV therapy.

J. Bartlett, R. Moore, 1998, Scientific American.

Costs of HIV medical care in the era of highly active antiretroviral therapy.

Richard D Moore, R. Chaisson, J. Bartlett, 1999, AIDS.

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.

R. Chaisson, R. Moore, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Potential factors affecting adherence with HIV therapy

N. Graham, R. Moore, S. Mehta, 1997, AIDS.

Risk factors for nephrotoxicity in patients treated with aminoglycosides.

E. Mellits, R. Moore, P. Lietman, 1984, Annals of internal medicine.

Zidovudine and the natural history of the acquired immunodeficiency syndrome.

R. Chaisson, R. Moore, R D Moore, 1991, The New England journal of medicine.

Self-reported antiretroviral therapy in injection drug users.

V. M. Shadle, D. Vlahov, D. Celentano, 1998, JAMA.

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

A. Wu, R. Chaisson, L. Eldred, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program.

D. Spyker, R. Moore, C. Wright, 1993, Alcoholism, clinical and experimental research.

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

M. Budoff, J. Willig, J. A. Delaney, 2014, American journal of epidemiology.

Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors

L. Kucirka, S. Boswell, M. Gill, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A study of thrombocytopenia. New histologic criteria for the differentiation of idiopathic thrombocytopenia and thrombocytopenia associated with disseminated lupus erythematosus.

R. Moore, O. Ratnoff, R. Breckenridge, 1967, Blood.

Weight gain following antiretroviral therapy (ART) initiation in ART-naïve people living with HIV in the current treatment era.

Brian R Wood, S. Lindström, M. Saag, 2020, Journal of acquired immune deficiency syndromes.

Community‐Acquired Pneumonia: Impact of Immune Status

J. Bartlett, T. Quinn, C. Gaydos, 1996, American journal of respiratory and critical care medicine.

Substance abuse-related admissions to adult intensive care.

T G Buchman, M. Breslow, B. Rosenfeld, 1993, Chest.

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1992, AIDS.

Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Keruly, 1991, Archives of internal medicine.

Racial differences in the use of drug therapy for HIV disease in an urban community.

R. Chaisson, R. Moore, R. Gopalan, 1994, The New England journal of medicine.

Utilization of computed tomography in patients hospitalized with community-acquired pneumonia.

L. Hofmann, J. Kuhlman, R. Moore, 1998, Maryland medical journal.

Evaluation of a model curriculum on substance abuse at The Johns Hopkins University School of Medicine

R. Moore, R. Gopalan, E. Stokes, 1992, Academic medicine : journal of the Association of American Medical Colleges.

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.

R. Chaisson, K. Gebo, J. Keruly, 1996, The Journal of infectious diseases.

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

J. Hackman, R. Chaisson, R. Moore, 2001, The American journal of medicine.

Prior antimicrobials and staphylococcal bacteremia in HIV‐infected patients

R. Chaisson, R. Moore, Barbara A. Styrt, 1997, AIDS.

Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis.

E. Bass, G. Petersen, F. Giardiello, 1998, Gastroenterology.

Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.

N. Powe, E. Fishman, J. Brinker, 1992, Radiology.

Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1991, JAMA.

A model for predicting nephrotoxicity in patients treated with aminoglycosides.

S. Lerner, R. Moore, C. Sawyers, 1986, The Journal of infectious diseases.

Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.

R. Chaisson, M. Glesby, R. Moore, 1993, The Journal of infectious diseases.

Alcohol consumption and blood pressure in the 1982 Maryland Hypertension Survey.

R. Moore, J. Southard, S. Shapiro, 1990, American journal of hypertension.

Competing risk adjustment reduces overestimation of opportunistic infection rates in AIDS.

D. Hoover, R. Moore, Y. Yan, 2000, Journal of clinical epidemiology.

Functional status of persons with HIV infection in an ambulatory setting.

A. Wu, R. Chaisson, R. Moore, 1994, Journal of acquired immune deficiency syndromes.

CLINICAL RESPONSE TO AMINOGLYCOSIDE THERAPY CONCENTRATIONS

R. Moore, C. R. Smith, P. Leitman, 1987 .

Duration of the survival benefit of zidovudine therapy in HIV infection.

R. Chaisson, J. Keruly, R. Moore, 1996, Archives of internal medicine.

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.

R. Chaisson, J. Gallant, J. Keruly, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography.

N. Powe, G. Anderson, J. Brinker, 1993, Journal of the American College of Cardiology.

Combination antiretroviral therapy in HIV infection. An economic perspective.

J. Bartlett, R. Moore, 1996, PharmacoEconomics.

Zidovudine therapy and health resource utilization in AIDS.

R. Chaisson, R. Moore, J. Bareta, 1994, Journal of acquired immune deficiency syndromes.

Comparative cost effectiveness of gentamicin and tobramycin.

R. Moore, E. Feroli, P. Lietman, 1984, Annals of internal medicine.

Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland.

R. Moore, I. Fortgang, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.

R. Moore, P. Lietman, C. R. Smith, 1986, Archives of internal medicine.

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.

D. Wheeler, I. Holme, David Talbot, 2001, Kidney international.

Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Gallant, 1994, Archives of internal medicine.

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation.

M. Schreier, R. Moore, J. Castaigne, 1995, Transplantation.

Effectiveness of medical consultation.

D. Levine, R. Moore, S. Kirby, 1983, Journal of medical education.

The efficacy of zidovudine is time limited.

R. Chaisson, R. Moore, J. Hidalgo, 1994, Journal of the American Medical Association (JAMA).

Community-acquired pneumonia: impact of immune status.

Richard D Moore, R. Moore, P. Auwaerter, 1995 .

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

J. Willig, J. A. Delaney, P. Crane, 2014, American journal of epidemiology.